AngioDynamics (ANGO) Appoints George Bourne as Tech Chief

May 21, 2012 6:33 AM EDT
AngioDynamics (Nasdaq: ANGO), has appointed George W. Bourne as Senior Vice President and Chief Technology Officer, effective immediately. He joins the Company's executive leadership team reporting to President and CEO Joseph M. DeVivo.

Mr. Bourne served as Senior Vice President of R&D and Clinical Affairs for Navilyst Medical from its formation in early 2008 until November 2011. His tenure was defined by focused portfolio development and the commercialization of new products. Most recently, Mr. Bourne served as VP of R&D at Hologic. Previously, he spent 10 years at Boston Scientific as Vice President, R&D, of the Urology, Meditech and Oncology business units and then as Group Vice President, R&D, for the endosurgery business group. Mr. Bourne, who earned his Bachelor of Science in Biological Science and Master of Science in Plastics Engineering from the University of Lowell, in addition to his MBA from Rivier College in Nashua, N.H., also served in leadership positions at Baxter Healthcare, Allegiance Healthcare and C.R. Bard.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Management Changes